SEB European Defence & Security Fund

In response to the deteriorated security situation in Europe, the region now needs to significantly increase its security and defence investments. SEB strives to contribute to strengthening Europe’s defence, security and resilience by offering investment opportunities in companies that are key players in the development of a stronger and safer Europe.

The Fund may invest in companies involved in nuclear weapons if the company has its headquarters or principal place of business in a NATO, EU or EEA country and has effective and credible mechanisms to ensure respect for human rights. The fund may not invest in controversial weapons (such as cluster bombs, land mines, depleted uranium munitions, and chemical and biological weapons), or companies that derive more than five percent of their revenues from the production or sale of civilian weapons.

SEB European Defence & Security Fund

A number of funds that invest in equities and corporate bonds can invest in the defence industry. The funds may within the framework of their investment orientation invest in conventional defence industries, but may not invest in companies that contribute to the development of nuclear weapons programmes or the production of nuclear weapons, are involved in the production, development or sale of prohibited or controversial weapons (such as cluster munitions, land mines, depleted uranium munitions, and chemical and biological weapons), or companies that derive more than five percent of their revenues from the production or sale of civilian weapons. The funds are not allowed to invest in companies that lack effective and credible mechanisms to ensure human rights.

Funds that can invest in conventional defence industry

Other funds that exclude companies which:

• manufacture, develop, or sell controversial weapons (defined as land mines, biological weapons, chemical weapons, cluster weapons and depleted uranium ammunition);
• are involved in the development, testing, production, manufacturing, acquisition, possession or stockpiling of nuclear weapons, subject to the following criteria;
• lack effective and credible mechanisms for ensuring human rights;
• derive more than five per cent of their revenue from the development, production and service of combat equipment; and
• derive more than five percent of their revenues from the production or sale of civilian weapons.